230
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and safety of tabalumab plus standard of care in Japanese patients with active systemic lupus erythematosus: Subgroup analyses of the ILLUMINATE-1 study

, , , , &
Pages 284-291 | Received 25 Mar 2016, Accepted 12 Jun 2016, Published online: 29 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zdenka Hruskova & Vladimir Tesar. (2018) Lessons learned from the failure of several recent trials with biologic treatment in systemic lupus erythematosus. Expert Opinion on Biological Therapy 18:9, pages 989-996.
Read now

Articles from other publishers (6)

José L. Gómez-Urquiza, José L. Romero-Bejar, Sara Chami-Peña, Nora Suleiman-Martos, Guillermo A. Cañadas-De la Fuente, Esther Molina & Blanca Riquelme-Gallego. (2023) Efficacy and Safety of New B Cell-Targeted Biologic Agent for the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 12:14, pages 4848.
Crossref
Yoshiya Tanaka, Sean O'Neill, Mengtao Li, I‐Ching Tsai & Ya‐Wen Yang. (2022) Systemic Lupus Erythematosus: Targeted Literature Review of the Epidemiology, Current Treatment, and Disease Burden in the Asia Pacific Region. Arthritis Care & Research 74:2, pages 187-198.
Crossref
Natalie M. Edner, Gianluca Carlesso, James S. Rush & Lucy S. K. Walker. (2020) Targeting co-stimulatory molecules in autoimmune disease. Nature Reviews Drug Discovery 19:12, pages 860-883.
Crossref
Shima Afzali, Saeedeh Salehi, Abbas Shahi & Aliakbar Amirzargar. (2020) B cell modulation strategies in the improvement of transplantation outcomes. Molecular Immunology 125, pages 140-150.
Crossref
Shereen Oon, Molla Huq, Timothy Godfrey & Mandana Nikpour. (2018) Systematic review, and meta-analysis of steroid-sparing effect, of biologic agents in randomized, placebo-controlled phase 3 trials for systemic lupus erythematosus. Seminars in Arthritis and Rheumatism 48:2, pages 221-239.
Crossref
Stamatis-Nick C. Liossis & Chrysanthi Staveri. (2017) B Cell-Based Treatments in SLE: Past Experience and Current Directions. Current Rheumatology Reports 19:12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.